CR Cancer Research Results

CR, Complete Response: Click to Expand ⟱
Source:
Type:
Scientific Papers found: Click to Expand⟱
7621- HPT,  Rad,    Clinical effectiveness of combined whole body hyperthermia and external beam radiation therapy (EBRT) versus EBRT alone in patients with painful bony metastases: A phase III clinical trial study
- Trial, Pca, NA - Trial, BC, NA
Pain↓, Dose↝, CR↑,
7624- HPT,  Chemo,    A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer
- Trial, Cerv, NA
OS↑, CR↑, *toxicity↓,
7627- HPT,  Rad,    Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
CR↑, OS↑, *toxicity↝, RadioS↑,
8173- Lap,  Tras,    Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials
- Review, BC, NA
CR↑, EFS↑, OS↑, toxicity↝,

Showing Research Papers: 1 to 4 of 4

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

CR↑, 4,   EFS↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 1,   RadioS↑, 1,  

Functional Outcomes(tgid=23) ⓘ

OS↑, 3,   Pain↓, 1,   toxicity↝, 1,  
Total Targets: 7

Pathway results for Effect on Normal Cells:


Functional Outcomes(tgid=23) ⓘ

toxicity↓, 1,   toxicity↝, 1,  
Total Targets: 2

Scientific Paper Hit Count for: CR, Complete Response
3 Hyperthermia
2 Radiotherapy/Radiation
1 Chemotherapy
1 Lapatinib
1 Trastuzumab
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:1  prod#:%  Target#:1672  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page